For instance, it has been discovered to promote ferroptosis in NSCLC by modulating SLC7A11/GPX4, and it can induce ferroptosis in glioma cells by the ACSL4/GPX4 pathway, thus providing antitumor benefits (Liu et al. 2022b; Hacioglu and Kar 2023). This evidence concerns the gene GPX4 and central nervous system cancer.